Take a look at the research highlights of 2019 as we count down the top infectious disease stories from A to Z!
Browsing: Disease Area > Fungal
Take a look behind the scenes of a recent Future Microbiology review, entitled ‘Anti-Candida activity of existing antibiotics and their derivatives when used alone or in combination with antifungals’ as we ask the authors about Candida infections, the potential repurposing of antibiotics and the future of this field.
Researchers at Dartmouth’s Geisel School of Medicine have found that hypoxic conditions are linked to a hypoxia-typic morphotype of the pathogen Aspergillus fumigatus. This morphotype worsens the diseases progression of invasive aspergillosis in a murine model.
In this interview, Paul Rowley (University of Idaho, ID, USA) speaks about his research identifying novel antifungal proteins from Saccharomyces cerevisiae yeasts and whether these could be translated into the medications of the future.
New research suggests that higher global temperatures could have prompted an adaptation in Candida auris, allowing it to infect warm-blooded mammals.
Results from the Centers for Disease Control and Prevention has provided insights into why Candida auris outbreaks frequent in healthcare facilities.
The oral antifungal drug fluconazole, which is used to treat vaginal yeast infections, has been linked to higher rates of miscarriage if used during pregnancy, according to new research.
Researchers have discovered Candida albicans can cross the blood–brain barrier, triggering an immune response that results in the formation of granuloma-type structures and memory impairments.
Researchers have successfully used monoclonal antibodies to protect animal models from Candida infections for the first time, demonstrating their potential for treating this fungal disease.
Want to discover the best research that’s occurred this year? Editor, Martha Powell, highlights the best of 2018’s infectious diseases research in an A–Z.